Herbal isoprenols induce apoptosis in human colon cancer cells through transcriptional activation of PPARγ

Cancer Investigation

Volumn 26, Issue 7, 2008, Pages 708-717

  Au Yeung, Kathy Ka Wai ^a   Liu, Po Ling ^a   Chan, Cecilia ^a   Wu, Wing Yee ^a   Lee, Susanna Sau Tuen ^b   Ko, Joshua Ka Shun ^a  

^a HONG KONG BAPTIST UNIVERSITY   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

FOH; GGOH; GW9662; HCT116 cells; HT 29 cells; PPAR

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; CASPASE 3; FARNESOL; GERANYLGERANIOL; ISOPRENALINE; ISOPRENOID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN BCL XL; SURVIVIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL STRAIN HCT116; CHROMATIN CONDENSATION; COLON CANCER; ENZYME ACTIVATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION INITIATION;

ANILIDES; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BCL-X PROTEIN; CASPASE 3; CELL PROLIFERATION; CELL SURVIVAL; COLONIC NEOPLASMS; DITERPENES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; FARNESOL; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HT29 CELLS; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; POLY(ADP-RIBOSE) POLYMERASES; PPAR GAMMA; PROMOTER REGIONS (GENETICS); TIME FACTORS; TRANS-ACTIVATION (GENETICS);

EID: 48249118758     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1080/07357900801898656     Document Type: Article

References (36)

1. Moertel, C.G.; Fleming, T.R.; Macdonald, J.S.; et al. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med 1990, 22, 352-358.
2. De Gramont, A.; Figer, A.; Seymour, M.; et al. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 2000, 18, 2938-2947.
3. Tin, M.M.; Cho, C.H.; Chan, K.; James, A.E.; Ko, J.K. Astragalus saponins induce growth inhibition and apoptosis in human colon cancer cells and tumor xenograft. Carcinogen 2007, 28, 1347-1355.
4. Ko, J.K.; Leung, W.C.; Ho, W.K.; Chiu, P. Herbal diterpenoids induce growth arrest and apoptosis in colon cancer cells with increased expression of the nonsteroidal anti-inflammatory drug-activated gene. Eur J Pharmacol 2007, 559, 1-13.
5. Sacchettini, J.C.; Poulter, C.D.. Creating isoprenoid diversity. Science. 1997, 277, 1788-1789.
6. Edwards, P.A.; Ericsson J. Sterols and isoprenoids: signaling molecules derived from the cholesterol biosynthetic pathway. Ann Rev Biochem 1999, 68, 157-185.
7. Haug, J.S., Goldner, C.M.; Yazlovitskaya, E.M.; Voziyan, P.A.; Melnykovych, G. Directed cell killing (apoptosis) in human lymphoblastoid cells incubated in the presence of farnesol: effect of phosphatidylcholine. Biochim Biophys Acta 1994, 1223, 133-140.
8. Ohizumi, H.; Masuda, Y.; Nakajo, S.; Sakai, I.; Ohsawa, S.; Nakaya, K. Geranylgeraniol is a potent inducer of apoptosis in tumor cells. J Biochem (Tokyo). 1995, 117, 11-13.
9. Miquel, K.; Pradines, A.; Favre, G. Farnesol and geranylgeraniol induce actin cytoskeleton disorganization and apoptosis in A549 lung adenocarcinoma cells. Biochem Biophys Res Commun 1996, 225, 869-876.
10. Masuda, Y.; Nakaya, M.; Nakajo, S.; Nakaya, K. Geranylgeraniol potently induces caspase-3-like activity during apoptosis in human leukemia U937 cells. Biochem Biophys Res Commun 1997, 234, 641-645.
11. Takeda, Y.; Nakao, K.; Nakata, K.; et al. Geranylgeraniol, an intermediate product in mevalonate pathway, induces apoptotic cell death in human hepatoma cells: death receptor-independent activation of caspase-8 with down-regulation of Bcl-xL expression. Jpn J Cancer Res 2001, 92, 918-925.
12. Issemann, I.; Green, S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 1990, 347, 645-650.
13. Escher, P.; Wahli, W. Peroxisome proliferator-activated receptors: insight into multiple cellular functions. Mutat Res 2000, 448, 121-138.
14. Roberts-Thomson, S.J. Peroxisome proliferator-activated receptors in tumorigenesis: targets of tumour promotion and treatment. Immunol Cell Biol 2000, 78, 436-441.
15. Gupta, R.A.; Dubois, R.N. Controversy: PPARgamma as a target for treatment of colorectal cancer. Am J Physiol Gastrointest Liver Physiol 2002, 283, G266-G269.
16. Sato, H.; Ishihara, S.; Kawashima, K.; et al. Expression of peroxisome proliferator-activated receptor (PPAR)gamma in gastric cancer and inhibitory effects of PPARgamma agonists. Br J Cancer 2000, 83, 1394-1400.
17. Shiau, C.W.; Yang, C.C.; Kulp, S.K. et al. Thiazolidenediones mediate apoptosis in prostate cancer cells in part through inhibition of Bcl-xL/Bcl-2 functions independently of PPARgamma. Cancer Res 2005, 65, 1561-1569.
18. Perez-Ortiz, J.M.; Tranque, P.; Vaquero, C.F.; et al. Glitazones differentially regulate primary astrocyte and glioma cell survival. Involvement of reactive oxygen species and peroxisome proliferator-activated receptor-gamma. J Biol Chem 2004, 279, 8976-8985.
19. Clay, C.E.; Monjazeb, A.; Thorburn, J.; Chilton, F.H. High KP. 15-Deoxy-delta 12,14-prostaglandin J2-induced apoptosis does not require PPARgamma in breast cancer cells. J Lipid Res 2002, 43, 1818-1828.
20. Takahashi, N.; Kawada, T.; Goto, T.; et al. Dual action of isoprenols from herbal medicines on both PPARgamma and PPARalpha in 3T3-L1 adipocytes and HepG2 hepatocytes. FEBS Lett 2002, 514, 315-322.
21. Hodgson, V.J.; Walker, G.M.; Button, D. A rapid colorimetric assay of killer toxin activity in yeast. FEMS Microbiol Lett 1994, 120, 201-205.
22. Marcus, S.L.; Miyata, K.S.; Zhang, B.; Subramani, S.; Rachubinski, R.A.; Capone, J.P. Diverse peroxisome proliferator-activated receptors bind to the peroxisome proliferator-responsive elements of the rat hydratase/dehydrogenase and fatty acyl-CoA oxidase genes but differentially induce expression. Proc Natl Acad Sci USA 1993, 90, 5723-5727.
23. Kim, R.; Tanabe, K.; Uchida, Y.; Emi, M.; Inoue, H.; Toge, T. Current status of the molecular mechanisms of anticancer drug-induced apoptosis, Cancer Chemother Pharmacol 2002, 50, 343-352.
24. Debatin, K.M. Apoptosis pathways in cancer and cancer therapy. Cancer Immunol Immunother 2004, 53, 153-159.
25. Kastan, M.B.; Bartek, J. Cell-cycle checkpoints and cancer. Nature 2004, 432, 316-323.
26. Reed, J.C.; Mechanisms of apoptosis avoidance in cancer. Curr Opin Oncol 1999, 11, 68-75
27. Sertznig, P.; Seifert, M., Tilgen, W., Reichrath, J. Present concepts and future outlook: Function of peroxisome proliferator-activated receptors (PPARs) for pathogenesis, progression, and therapy of cancer. J Cell Physiol 2007, 212, 1-12.
28. Koeffler, H.P. Peroxisome proliferator-activated receptor gamma and cancers. Clin Cancer Res 2003, 9, 1-9.
29. Chen, G.G.; Lee, J.F.; Wang, S.H.; Chan, U.P.; Ip, P.C.; Lau, W.Y. Apoptosis induced by activation of peroxisome-proliferator activated receptor-gamma is associated with Bcl-2 and NF-kappaB in human colon cancer. Life Sci 2002, 70, 2631-2646.
30. Lefebvre, A.M.; Chen, I.; Desreumaux, P.; et al. Activation of the peroxisome proliferator-activated receptor gamma promotes the development of colon tumors in C57BL/6J-APCMin/+ mice. Nat Med 1998, 4, 1053-1057.
31. O'Brien, M.L.; Rangwala, S.M.; Henry, K.W.; Weinberger, C.; Crick, D.C.; Waechter, C.J.; Feller, D.R.; Noonan, D.J. Convergence of three steroid receptor pathways in the mediation of nongenotoxic hepatocarcinogenesis. Carcinogene 1996, 17, 185-190.
32. Baek, S.J.; Wilson, L.C.; His, L.C.; Eling, T.E. Troglitazone, a peroxisome proliferator-activated receptor gamma (PPAR gamma) ligand, selectively induces the early growth response-1 gene independently of PPAR gamma. A novel mechanism for its antitumorigenic activity. J Biol Chem 2003, 278, 5845-53
33. Carnesecchi, S.; Schneider, Y.; Ceraline, J.; et al. Geraniol, a component of plant essential oils, inhibits growth and polyamine biosynthesis in human colon cancer cells. J Pharmacol Exp Ther 2001, 298, 197-200.
34. He, L.; Mo, H.; Hadisusilo, S.; Qureshi, A.A.; Elson, C.E. Isoprenoids suppress the growth of murine B16 melanomas in vitro and in vivo. J Nutr 1997, 127, 668-674.
35. Sporn, M.B.; Suh, N.; Mangelsdorf, D.J. Prospects for prevention and treatment of cancer with selective PPARγ modulators (SPARMs). Trends Mol Med 2001, 7, 395-400.
36. Rumi, M.A.K; Ishihara, S., Kadowaki, Y.; et al. Peroxisome proliferator-activated receptor γ-dependent and -independent growth inhibition of gastrointestinal tumor cells. Genes Cells 2004, 9, 1113-1123.